151 related articles for article (PubMed ID: 10498635)
1. Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?
Krzeski P; Zych W; Kraszewska E; Milewski B; Butruk E; Habior A
Hepatology; 1999 Oct; 30(4):865-9. PubMed ID: 10498635
[TBL] [Abstract][Full Text] [Related]
2. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
Kilmurry MR; Heathcote EJ; Cauch-Dudek K; O'Rourke K; Bailey RJ; Blendis LM; Ghent CN; Minuk GY; Pappas SC; Scully LJ; Steinbrecher UP; Sutherland LR; Williams CN; Worobetz LJ
Hepatology; 1996 May; 23(5):1148-53. PubMed ID: 8621147
[TBL] [Abstract][Full Text] [Related]
3. Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.
Reisman Y; van Dam GM; Gips CH; Lavelle SM; Euricterus PM
Hepatogastroenterology; 1997; 44(16):982-9. PubMed ID: 9261586
[TBL] [Abstract][Full Text] [Related]
4. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis.
Bonnand AM; Heathcote EJ; Lindor KD; Poupon RE
Hepatology; 1999 Jan; 29(1):39-43. PubMed ID: 9862847
[TBL] [Abstract][Full Text] [Related]
7. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation.
van Dam GM; Verbaan BW; Therneau TM; Dickson ER; Malinchoc M; Murtaugh PA; Huizenga JR; Gips CH
Hepatogastroenterology; 1997; 44(15):732-43. PubMed ID: 9222682
[TBL] [Abstract][Full Text] [Related]
8. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group.
Poupon RE; Bonnand AM; Chrétien Y; Poupon R
Hepatology; 1999 Jun; 29(6):1668-71. PubMed ID: 10347106
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
[TBL] [Abstract][Full Text] [Related]
10. Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study.
van Dam GM; Gips CH; Reisman Y; Maas KW; Purmer IM; Huizenga JR; Verbaan BW
Hepatogastroenterology; 1999; 46(25):108-15. PubMed ID: 10228773
[TBL] [Abstract][Full Text] [Related]
11. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.
Su CW; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Lee PC; Lee SD; Wu JC
Liver Int; 2008 Nov; 28(9):1305-13. PubMed ID: 18346129
[TBL] [Abstract][Full Text] [Related]
12. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.
Kim WR; Poterucha JJ; Wiesner RH; LaRusso NF; Lindor KD; Petz J; Therneau TM; Malinchoc M; Dickson ER
Hepatology; 1999 Jun; 29(6):1643-8. PubMed ID: 10347102
[TBL] [Abstract][Full Text] [Related]
13. Natural history of pruritus in primary biliary cirrhosis.
Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates.
Kim WR; Wiesner RH; Poterucha JJ; Therneau TM; Benson JT; Krom RA; Dickson ER
Liver Transpl; 2000 Jul; 6(4):489-94. PubMed ID: 10915173
[TBL] [Abstract][Full Text] [Related]
15. Value of baseline platelet count for prediction of complications in primary biliary cirrhosis patients treated with ursodeoxycholic acid.
Huang YL; Yao DK; Hu ZD; Sun Y; Chen SX; Zhong RQ; Deng AM
Scand J Clin Lab Invest; 2013 Feb; 73(1):17-23. PubMed ID: 23294193
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.
Boberg KM; Rocca G; Egeland T; Bergquist A; Broomé U; Caballeria L; Chapman R; Hultcrantz R; Mitchell S; Pares A; Rosina F; Schrumpf E
Hepatology; 2002 Mar; 35(3):652-7. PubMed ID: 11870380
[TBL] [Abstract][Full Text] [Related]
17. Optimal timing of liver transplantation for primary biliary cirrhosis.
Kim WR; Wiesner RH; Therneau TM; Poterucha JJ; Porayko MK; Evans RW; Klintmalm GB; Crippin JS; Krom RA; Dickson ER
Hepatology; 1998 Jul; 28(1):33-8. PubMed ID: 9657093
[TBL] [Abstract][Full Text] [Related]
18. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid.
Parés A; Caballería L; Rodés J
Gastroenterology; 2006 Mar; 130(3):715-20. PubMed ID: 16530513
[TBL] [Abstract][Full Text] [Related]
19. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis.
Wesierska-Gadek J; Penner E; Battezzati PM; Selmi C; Zuin M; Hitchman E; Worman HJ; Gershwin ME; Podda M; Invernizzi P
Hepatology; 2006 May; 43(5):1135-44. PubMed ID: 16628641
[TBL] [Abstract][Full Text] [Related]
20. Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis.
Longheval G; Vereerstraeten P; Thiry P; Delhaye M; Le Moine O; Devière J; Bourgeois N; Adler M
Liver Transpl; 2003 Mar; 9(3):260-7. PubMed ID: 12619023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
